LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
9.29
-0.60 (-6.07%)
Feb 21, 2025, 4:00 PM EST - Market closed
LENSAR Market Cap
LENSAR has a market cap or net worth of $107.90 million as of February 21, 2025. Its market cap has increased by 125.71% in one year.
Market Cap
107.90M
Enterprise Value
91.71M
1-Year Change
125.71%
Ranking
Category
Stock Price
$9.29
Market Cap Chart
Since October 2, 2020, LENSAR's market cap has increased from $78.01M to $107.90M, an increase of 38.32%. That is a compound annual growth rate of 7.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 107.90M | 3.91% |
| Dec 31, 2024 | 103.84M | 163.00% |
| Dec 29, 2023 | 39.48M | 21.00% |
| Dec 30, 2022 | 32.63M | -50.28% |
| Dec 31, 2021 | 65.63M | -14.91% |
| Dec 31, 2020 | 77.13M | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 782.62B |
| UnitedHealth Group | 464.46B |
| Johnson & Johnson | 384.35B |
| Novo Nordisk | 370.06B |
| AbbVie | 352.00B |
| Abbott Laboratories | 230.20B |
| AstraZeneca | 228.16B |
| Merck & Co. | 219.42B |